Drug Discovery Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)

The Global Drug Discovery Market is Segmented by Drug Type (Small Molecule Drugs and Biologic Drugs), Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, and Other Technologies), End User (Pharmaceutical Companies, Contract Research Organizations (CROs), and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers Market Forecasts and Revenues in Terms of Value in USD Million for the Above Segments.

Drug Discovery Market Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)

Drug Discovery Industry Overview

The drug discovery market is highly competitive and consists of a number of major players. The market players are implementing innovative strategies and adopting artificial intelligence and machine learning in drug discovery to speed up the process. Furthermore, the key market players are entering into strategic partnerships to develop novel drug molecules. Some of the companies in this market include Eli Lilly and Company, Novartis AG, Bayer AG, AbbVie Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Pfizer Inc., and Sanofi.

Drug Discovery Market Leaders

  1. Eli Lilly and Company

  2. Bristol-Myers Squibb Company

  3. Novartis AG

  4. Bayer AG

  5. AbbVie Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Drug Discovery Market Concentration